aristolochic acid i has been researched along with 2019 Novel Coronavirus Disease in 3 studies
aristolochic acid I: phospholipase A inhibitor
aristolochic acid A : An aristolochic acid that is phenanthrene-1-carboxylic acid that is substituted by a methylenedioxy group at the 3,4 positions, by a methoxy group at position 8, and by a nitro group at position 10. It is the most abundant of the aristolochic acids and is found in almost all Aristolochia (birthworts or pipevines) species. It has been tried in a number of treatments for inflammatory disorders, mainly in Chinese and folk medicine. However, there is concern over their use as aristolochic acid is both carcinogenic and nephrotoxic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "AH has no obvious toxicity to mice and is relatively safe when it is used in the form of decoction." | 1.91 | Long-term oral administration of Asarum heterotropoides f. mandshuricum (Maxim.) Kitag. decoction and its aristolochic acid analogs do not cause renal toxicity in mice. ( Han, J; Li, C; Liang, A; Liu, C; Liu, M; Liu, S; Meng, J; Pan, C; Qin, S; Tang, X; Tian, J; Wang, F; Wang, L; Wang, Y; Yi, Y; Zhang, Y; Zhao, Y, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mokos, M | 1 |
| Bašić-Jukić, N | 1 |
| Das, T | 1 |
| Mukerjee, N | 1 |
| Ghosh, A | 1 |
| Lorenzo, JM | 1 |
| Dhama, K | 1 |
| Dey, A | 1 |
| Liu, M | 1 |
| Wang, L | 2 |
| Qin, S | 1 |
| Zhao, Y | 1 |
| Liu, S | 1 |
| Yi, Y | 1 |
| Li, C | 1 |
| Tian, J | 1 |
| Liu, C | 1 |
| Meng, J | 1 |
| Wang, Y | 1 |
| Zhang, Y | 1 |
| Wang, F | 1 |
| Pan, C | 1 |
| Han, J | 1 |
| Tang, X | 1 |
| Liang, A | 1 |
3 other studies available for aristolochic acid i and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
IgA nephropathy following SARS-CoV-2 vaccination in a renal transplant recipient with a history of aristolochic acid nephropathy.
Topics: Aristolochic Acids; COVID-19; COVID-19 Vaccines; Female; Glomerulonephritis, IGA; Humans; Kidney Tra | 2022 |
Growing risk of aristolochic acid nephropathy in the era of COVID-19 - Correspondence.
Topics: Aristolochic Acids; COVID-19; Humans; Kidney Diseases | 2022 |
Long-term oral administration of Asarum heterotropoides f. mandshuricum (Maxim.) Kitag. decoction and its aristolochic acid analogs do not cause renal toxicity in mice.
Topics: Animals; Aristolochic Acids; Asarum; COVID-19; Humans; Kidney; Mice | 2023 |